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in Older Adults with Dementia
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Kenneth M. Langa, MD, PhD,†‡§¶ and Helen C. Kales, MD*†‡
OBJECTIVES: Reducing potentially preventable hospitali-
zation (PPH) among older adults with dementia is a goal of
Healthy People 2020, yet no tools specifically identify
patients with dementia at highest risk. The objective was to
develop a risk prediction model to identify older adults with
dementia at high imminent risk of PPH.
DESIGN: A 30-day risk prediction model was developed
using multivariable logistic regression. Patients from fiscal
years (FY) 2009 to 2011 were split into development and
validation cohorts; FY2012 was used for prediction.
SETTING: Community-dwelling older adults (≥65 years of
age) with dementia who received care through the Veterans
Health Administration.
PARTICIPANTS: There were 1 793 783 participants.
MEASUREMENTS: Characteristics associated with hospi-
talization risk were (1) age and other demographic factors;
(2) outpatient, emergency department, and inpatient utiliza-
tion; (3) medical and psychiatric diagnoses; and (4) pre-
scribed medication use including changes to psychotropic
medications (eg, initiation or dosage increase). Model dis-
crimination was determined by the C statistic for each of
the three cohorts. Finally, to determine whether predicted
30-day risk strata were stable over time, the observed PPH
rate was calculated out to 1 year.
RESULTS: In the development cohort, .6% of patients experi-
enced PPH within 30 days. The C statistic for the development
cohort was .83 (95% confidence interval [CI] = .83-.84) and
.83 in the prediction cohort (95% CI = .82-.84). Patients in
the top 10% of predicted 30-day PPH risk accounted for more
than 50% of 30-day PPH admissions in all three cohorts. In
addition, those predicted to be at elevated 30-day risk remained
at higher risk throughout a year of follow-up.
CONCLUSION: It is possible to identify older adults with
dementia at high risk of imminent PPH, and their risk remains
elevated for an entire year. Given the negative outcomes associ-
ated with acute hospitalization for those with dementia,
healthcare systems and providers may be able to engage these
high-risk patients proactively to avoid unnecessary hospitaliza-
tion. J AmGeriatr Soc 67:2077-2084, 2019.
Key words: dementia; potentially preventable hospitali-
zation; risk prediction
Patients with dementia have an all-cause hospitalizationrate approximately 1.4 times higher than other older
adults, and potentially preventable hospitalization (PPH) is
nearly 1.8-times higher.1 PPH captures admission for ambula-
tory care-sensitive conditions such as congestive heart failure
(CHF) or pneumonia, that, with optimal outpatient access and
management, are potentially unnecessary. Reduction of PPH
specifically in older adults with dementia is a goal of Healthy
People 2020.2,3 Their elevated hospitalization risk is worrying
because, although all older adults are at increased risk of
hospitalization-associated delirium, iatrogenic complications,
and cognitive and functional decline,4-6 the consequences are
greater for patients with dementia,7,8 for whom cognitive or
functional decline are risk factors for institutionalization.9,10
As the population with dementia nearly triples by
2050,11 even small reductions in the rate of PPH could have
a large impact. Unfortunately, no controlled dementia care
intervention trials have demonstrated a reduction in hospi-
talization.12,13 One possible reason is the trials were not
specifically designed to target patients at the highest risk of
hospitalization. Given the potential adverse consequences of
hospitalization for older adults with dementia, identifying
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those at high risk before they need to be hospitalized, espe-
cially admissions for conditions that could potentially be
treated in an outpatient setting, is critical.
Approaches to risk-stratify patients with dementia
that do not rely on overburdened primary care clini-
cians14 is key to appropriately targeting supports that
may benefit these older adults and their caregivers.15 For
this analysis, we used national data from the US Veterans
Health Administration (VHA) electronic health record
(EHR) to develop a multivariable logistic regression
model to predict PPH admission within 30 days (develop-
mental cohort). We then used the model to identify risk
tiers among a different cohort of older adults with
dementia (validation cohort) and determine whether the
model could accurately predict risk among the new set of
patients (prediction cohort).
METHODS
Study Sample and Outcome
The study sample (n = 1 793 783) was drawn from older
adults treated in the VHA from October 1, 2008, through
September 30, 2012 (fiscal years [FY] 2009-2012). The first
index date was October 1, 2008 (ie, the start of FY2009),
with a cohort including patients who met these four inclusion
criteria: (1) 65 years of age or older; (2) at least one inpatient
or outpatient encounter within the previous 12 months to
establish use of VHA services; (3) dementia diagnosis before
index date (based on one or more encounter with one of the
following International Classification of Diseases, Ninth Revi-
sion, Clinical Modification (ICD-9-CM) codes, as used in pre-
vious work16-18: 046.1, 046.3, 290.0, 290.1x, 290.2x, 290.3,
290.4x, 291.2, 294.10, 294.11, 331.0, 331.1, and 331.82);
and (4) not in a VHA inpatient or long-term care setting on
the index date.
Then we expanded the cohort by moving the index
date ahead at 2-month intervals from December 1, 2008;
February 1, 2009; and so on, through August 1, 2012. All
patients who met the four inclusion criteria at the index
date of each 2-month interval (eg, on December 1, 2008)
were considered at risk for PPH and included in the cohort.
Therefore, a single patient could contribute multiple at-risk
intervals to the final cohort.
The event of interest was PPH admission within
30 days of entering the cohort (ie, the index date). We
defined PPH using the primary ICD-9-CM discharge diag-
nosis (Table S1) for the inpatient admission, applying the
Agency for Healthcare Research and Quality (AHRQ) pre-
vention quality indicators19 that include conditions both
acute (eg, dehydration, bacterial pneumonia, kidney or uri-
nary tract infection) and chronic (diabetes, asthma, chronic
obstructive pulmonary disease, hypertension, CHF exacer-
bation, angina). To be consistent with prior studies,1,3,20 we
also included cellulitis, gastric/duodenal/peptic ulcer, ear/
nose/throat infection, gastroenteritis, hypoglycemia, hypo-
kalemia, influenza, malnutrition, and seizure disorder. The
total cohort from the first 3 years (FY2009-2011) was ran-
domly split into halves to develop and validate the predic-
tion model (n = 664 355 and 664 357, respectively); the
final year (FY2012; n = 465 071) was used as a prediction
cohort to apply the model.
Measures
Candidate model variables were chosen based on prior work
examining predictors of hospitalization in older adults.21-23
Demographic variables included age, sex, race (white, black,
other race, unknown race), Hispanic ethnicity, marital status
(married, single/never married, divorced, widowed, unknown),
and urbanicity (urban, rural, highly rural as defined by VHA
using US Census designations). Clinical characteristics included
length of time since the first dementia diagnosis (a proxy for
dementia severity, ascertained from records going back 10 y),
number of unique prescription medications as of the index
date, and presence of the following conditions based on clini-
cal encounters in the preceding 12 months (Table S1): diagno-
ses used to derive the Charlson Comorbidity Index; each PPH
condition; delirium (or other transient mental status change);
and individual psychiatric conditions including depression,
bipolar disorder, and anxiety disorders.
Service utilization characteristics included the number of
outpatient, inpatient, and emergency department visits for
specific pre-index intervals: 1, 2, 3, 6, 9, and 12 months.
Behavioral and psychological symptoms of dementia may
be associated with hospitalization risk,24,25 and the use of psy-
chotropic medications suggests these symptoms are present,26
so we used indicators of psychotropic (eg, antipsychotic, antide-
pressant, sedative/hypnotic, mood stabilizer) and antidementia
(eg, cholinesterase inhibitors and memantine) medication pre-
scribing: prevalent use, incident use, and dosage escalation.
Each psychotropic indicator was determined for 1, 2, 3, 6,
9, and 12 months pre-index, as well as on the index date.
Analysis
Our goal was to develop a model predicting 30-day PPH risk;
we followed an analytic plan similar to one used to develop
and validate a suicide risk prediction model among VHA
patients using the VHA EHR.27 To develop a model to predict
30-day PPH, we used the development cohort and fit multi-
variable logistic regression. Generalized estimation equation
with independence was used to adjust for potential correlation
from repeated inclusion of the same patients.
Because the medication and service utilization measures
were collected for several prespecified time intervals that
were potentially correlated (eg, antipsychotic use 1, 2, 3, 6,
9, and 12 months pre-index), we screened each set of mea-
sures separately to determine which were most predictive.
Based on the magnitude and significance of the parameter
estimates, 1 month pre-index was most predictive of PPH,
so the final model only included medication and service uti-
lization indicators from the month pre-index. Longer pre-
index intervals (eg, 3 or 6 months pre-index) did not further
add to model predictiveness, with parameter estimates close
to zero.
To allow for effect modification of diagnoses and uti-
lization measures by patient age, we also considered
variable-by-age interaction terms, but they were neither signifi-
cant nor improved the model fit so were not retained. For
continuous or count measures (age, number of outpatient
visits, etc), we included linear and square terms after centering
the measures to allow nonlinear relationships. We did not use
any additional variable reduction approaches and retained
all variables in the model regardless of statistical significance
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because our focus was on overall prediction of risk rather
than causal inferences related to specific characteristics and
the associated PPH risk.
We present the distribution of select patient sociodemo-
graphic and clinical characteristics in the development cohort
overall and among those with a PPH admission within
30 days or 1 year. Patient characteristics are described for
those at risk of PPH at all intervals; if a patient is at risk of
PPH in more than one interval, that person’s contribution to
the patient characteristics is considered as if from a different
patent for each interval. Therefore, the values of the predictors
corresponding to each time interval are all accounted for
separately.
Model discrimination was assessed by calculating the C
statistic in each of the three cohorts: development (half 1 of
FY2009-2011), validation (half 2 of FY2009-2011), and pre-
diction (FY2012). In each study cohort, based on the ranked
predicted probability of PPH admission within 30 days, we
set risk cut points starting with those patients with the top
.1% predicted probability down through lower, more inclu-
sive tiers of risk (eg, top .5%, 1.0%, 5.0%, etc). We exam-
ined risk concentration for each cut point by determining the
number of observed PPH admissions for patients in the risk
tier divided by the number of expected PPH admissions
based on the overall cohort PPH rate. We used the validation
cohort to display calibration graphically by deciles of
predicted risk and also used the Hosmer-Lemeshow test for
goodness of fit.
To appreciate the impact of applying the model to a
new set of patients, performance characteristics (sensitivity,
specificity, positive predictive value, and negative predictive
value) were determined in the prediction cohort using the
prespecified risk cut points.
Finally, to determine whether those at high imminent
(ie, 30-day) risk of PPH remained at high risk throughout
an entire year, we applied the 30-day PPH risk cut points to
the prediction cohort to determine each tier’s risk concen-
tration 1, 3, 6, and 12 months post-index. Statistical ana-
lyses were done using SAS v.9.4 (SAS Institute, Cary, NC).
RESULTS
Select demographic and clinical characteristics of the devel-
opment cohort are presented in Table 1 (all characteristics
are listed in Table S2) that included 664 355 adults with
dementia. The 30-day PPH rate was 69.7 per 1000 person-
years; 1-year PPH rate was 57.6 per 1000 person-years.
The PPH rate of black patients was nearly double that of
white patients. Those patients who experienced PPH within
30 days had more use of each type of inpatient and outpa-
tient service, as well as more of every category of psycho-
tropic medication use including dose increases in the pre-
index month.
The development model had very good discrimination,28
with a C statistic = .834 (95% confidence interval
[CI] = .827-.840); model coefficients are presented in Table S3.
When the model was applied to the validation and prediction
cohorts, there was only a slight loss of discrimination, with C
statistics of .832 (95% CI = .825-.838) and .829 (95%
CI = .821-.838), respectively. Figure 1 plots the expected
(predicted) and observed PPH admission rates by decile of
predicted risk for the validation cohort. The predicted rate was
close to the observed rate across deciles, although the model
slightly overestimated events in the lower deciles and slightly
underestimated among the highest risk groups. Although the
Hosmer-Lemeshow statistic was significant (χ2 = 159.8; df = 8;
P < .001), this is likely a function of the large sample size.
In each of the three cohorts of patients with dementia
(Table 2), among the top 1.0% of patients by predicted
30-day PPH probability, the observed PPH rate ranged
from 13.4 to 14.1 times higher than the crude rates (ie, risk
concentration). Little overfitting was indicated as seen by
the consistent risk concentration across all three cohorts for
each predicted probability cut point. Of note, patients in the
top 10% of predicted 30-day PPH risk accounted for 52.9%
to 53.9% of 30-day PPH admissions in each cohort. Perfor-
mance characteristics for various cut points of predicted risk
are presented in Table 3.
Finally, we applied our predicted 30-day probability
cut points to the prediction cohort to examine the trajectory
of risk (ie, observed PPH number, rate, and risk concentra-
tion) over 1 year (Figure 2 and Table S4). Older adults
predicted to be at high 30-day risk of PPH had an elevated
risk of admission for the entire year. For example, the top
1% had 13.4-times higher 30-day PPH risk than patients
with dementia overall during the first month, but over the
following year their 12-month PPH risk was still 7.7-times
higher than the 12-month risk for patients with dementia
overall.
DISCUSSION
Using data from more than 660 000 adults with dementia,
we developed a model that showed high discrimination for
predicting 30-day risk of PPH using information available
in the EHR. The model also had very good discrimination
in the validation cohort (C statistic = .83), indicating little
overfitting. Discrimination of the prediction model in the
prediction cohort was also high (C statistic = .83), and pre-
diction cohort patients at high 30-day risk remained at ele-
vated risk during 1 year of follow-up. Although this model
needs to be tested in other health systems to determine gen-
eralizability, our findings suggest this EHR-based approach
may be feasible.
We found a PPH risk gradient among older adults with
dementia: within the top .1%, 30-day risk of PPH was
nearly 20 times higher than among patients overall. Expan-
ding the definition of high risk to the top 10%, a fivefold
higher risk of 30-day PPH remained. Although risk concen-
tration did decrease over 12 months, those at high 30-day
risk maintained persistently elevated risk. A variety of
dementia care management and caregiver support programs
decreased caregiver burden, patient behavioral symptoms of
dementia, or time to nursing home placement,29-32 but
intervention trials typically did not reduce hospitalization.33
Null findings from randomized intervention trials may sug-
gest these interventions do not reduce hospitalization; an
alternative explanation is that participants were not risk-
stratified to maximize hospitalization impact. The GRACE
intervention trial, which provided care management for
low-income older adults (with or without dementia), dem-
onstrated this: there was no impact on hospitalization over-
all, but admissions were reduced in those who screened at
high risk of hospitalization at baseline.34 Given the growing
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Table 1. Select Demographic and Clinical Characteristics and 30-day and 1-year Rates of Potentially Preventable Hos-
pitalization among the Development Cohort
Characteristica N (%)
Patients with PPH
within 30 d, N (%)
Patients with PPH







All 664 355 3745 (.6) 31 962 (4.8) 69.7 57.6
Age, y
65-74 113 964 (17.2) 659 (17.6) 5732 (17.9) 71.5 58.9
75-84 322 642 (48.6) 1688 (45.1) 14 639 (45.8) 64.6 53.6
≥85 227 749 (34.3) 1398 (37.3) 11 591 (36.3) 76.1 63.0
Sex
Male 647 274 (97.4) 3646 (97.4) 31 088 (97.3) 69.7 57.6
Race
White 482 594 (72.6) 2743 (73.2) 23 214 (72.6) 70.3 57.5
Black 67 907 (10.2) 694 (18.5) 5971 (18.7) 127.1 109.6
Other races 15 463 (2.3) 100 (2.7) 943 (3.0) 80.0 73.4
Unknown or missing 98 391 (14.8) 208 (5.6) 1834 (5.7) 26.1 22.0
Hispanic ethnicity
Yes 17 794 (2.7) 156 (4.2) 1236 (3.9) 108.8 85.1
No 575 614 (86.6) 3421 (91.4) 29 277 (91.6) 73.5 60.9
Unknown or missing 70 947 (10.7) 168 (4.5) 1449 (4.5) 29.3 24.5
Marital status
Married 429 644 (64.7) 1903 (50.8) 16 399 (51.3) 54.7 45.0
Single/never married 35 670 (5.4) 294 (7.9) 2586 (8.1) 102.6 90.0
Divorced 79 610 (12.0) 651 (17.4) 5440 (17.0) 101.5 84.0
Widowed 116 469 (17.5) 889 (23.7) 7465 (23.4) 94.7 79.4
Unknown or missing 2962 (.4) 8 (.2) 72 (.2) 33.4 29.2
Residence
Urban 432 406 (65.1) 2670 (71.3) 22 558 (70.6) 76.4 62.9
Rural 224 684 (33.8) 1048 (28.0) 9159 (28.7) 57.6 48.2
Highly rural 7265 (1.1) 27 (.7) 245 (.8) 45.9 39.8
Diagnoses present in past 12 mo
Myocardial infarction 20 181 (3.0) 337 (9.0) 2182 (6.8) 210.0 144.1
Cerebrovascular disease 125 495 (18.9) 1256 (33.5) 10 227 (32.0) 124.7 102.9
Delirium or other transient
mental status change
280 286 (42.2) 2100 (56.1) 16 953 (53.0) 93.0 74.5
Depression 167 864 (25.3) 1249 (33.4) 10 508 (32.9) 92.2 76.3
Posttraumatic stress disorder 40 426 (6.1) 309 (8.3) 2545 (8.0) 94.7 76.3
Other anxiety disorders 48 414 (7.3) 413 (11.0) 3295 (10.3) 105.9 83.2
Duration of dementia, y
<1 165 081 (24.8) 1035 (27.6) 7811 (24.4) 77.7 56.8
1-3 292 349 (44.0) 1510 (40.3) 13 327 (41.7) 63.8 54.4
4-6 141 122 (21.2) 709 (18.9) 6645 (20.8) 62.1 56.3
≥7 65 803 (9.9) 491 (13.1) 4179 (13.1) 92.4 77.1
Type of dementia
Alzheimer’s disease 545 775 (82.2) 2794 (74.6) 24 050 (75.2) 63.3 52.6
Vascular dementia 175 687 (26.4) 1429 (38.2) 12 212 (38.2) 101.0 85.8
Lewy body dementia 32 098 (4.8) 236 (6.3) 1762 (5.5) 91.6 69.9
Progressive multifocal
leukoencephalopathy
256 (<.1) 2 (.1) 11 (<.1) 97.2 52.3
Jakob-Creutzfeldt disease 236 (<.1) 3 (.1) 21 (.1) 157.9 109.4
Alcoholic dementia 20 558 (3.1) 167 (4.5) 1419 (4.4) 101.0 85.4
Pick’s dementia 9980 (1.5) 59 (1.6) 533 (1.7) 73.1 64.4
Utilization in past month
Medical/surgical outpatient visits, n
0 336 372 (50.6) 732 (19.6) 7846 (24.5) 26.8 27.1
1 147 262 (22.2) 687 (18.3) 6753 (21.1) 57.5 54.1
2 77 930 (11.7) 564 (15.1) 5037 (15.8) 89.6 78.4
≥3 102 791 (15.5) 1762 (47.1) 12 326 (38.6) 216.1 162.1
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population of older adults with dementia, limited resources
call for risk stratification strategies to help target interventions
appropriately, rather than attempting to deliver a given inter-
vention to all.
Analyses based on claims or administrative data of
older adults can be subject to unobserved confounding by
factors such as frailty or functional status that are associ-
ated with health outcomes but not routinely available in
administrative data.35,36 Yet our model had excellent pre-
dictive ability derived entirely from structured information in
the EHR, without any additional information from the patient
or caregiver. In contrast, the Probability of Repeated Admis-
sion Instrument, used in the GRACE trial to identify the high-
risk patients at baseline, has to be completed by the older
adult and includes items on self-rated health and the presence
of an informal caregiver.37 Given the enormous demands on
primary care providers’ time,14 harnessing the EHR may be a
feasible means to risk-stratify these patients without requiring
any additional input from providers, patients, or caregivers.
The ability of our model to identify high-risk patients is
notable given that the overall cohort, older adults with demen-
tia, is, at baseline, at a significantly elevated risk of admission
compared with the general adult population. The predictive
ability of our model is comparable with a separately devel-
oped PPH predictive model for VA patients of all ages,23 but
our model discriminates slightly better than other risk models
specifically developed for older adults.22,38-41 A review of risk
stratification applied six different models: Adjusted Clinical
Groups, Hierarchical Condition Categories, Elder Risk Assess-
ment, Chronic Comorbidity Count, Charlson Comorbidity
Index, and Minnesota Health Care Home Tiering to more
than 80 000 primary care patients seen in a large academic
health system. Across the six models, the C statistic for 1-year
hospitalization prediction was .67 to .73.39
One specific model feature that may have facilitated
identifying high-risk patients was the inclusion of psycho-
tropic medications as predictors, specifically new medica-
tion starts and dosage increases. Changes to psychotropic
medications may herald the presence or worsening of symp-
toms such as agitation or psychosis.26,42 Such behavioral
and psychological symptoms of dementia may dominate the
clinical presentation of patients with dementia, and the
related caregiver distress is associated with increased hospi-
talization and costs for patients.25 Alternatively, such medi-
cation changes may be to treat delirium or other transient
changes in mental status that were recorded for more than
40% of cohort patients in the prior 12 months. Although
information about behavioral symptoms is typically not
available in the EHR or delirium may not be reliably
recorded, incorporating information about psychotropic
medication changes, which would be in the EHR, may help
identify patients whose behavioral problems either reflect a
worsening medical problem or are part of the constellation
of symptoms that led to hospital admission.42 Regardless of
the clinical rationale for such medication changes, this




within 30 d, N (%)
Patients with PPH







Acute inpatient hospitalizations, n
0 655 674 (98.7) 3314 (88.5) 29 992 (93.8) 62.4 54.5
1 8313 (1.3) 396 (10.6) 1851 (5.8) 640.5 403.9
≥2 368 (.1) 35 (.9) 119 (.4) 1412.7 824.0
Medications on index date, n
0 139 929 (21.1) 517 (13.8) 4178 (13.1) 45.9 36.8
1-2 93 255 (14.0) 265 (7.1) 2675 (8.4) 35.0 33.4
3-4 114 498 (17.2) 348 (9.3) 3678 (11.5) 37.4 37.1
5-6 109 603 (16.5) 537 (14.3) 4548 (14.2) 60.4 48.4
≥7 207 070 (31.2) 2078 (55.5) 16 883 (52.8) 124.6 100.6
Class of psychotropic use on index date
Antipsychotic 64 358 (9.7) 530 (14.2) 4378 (13.7) 102.4 86.0
Antidepressant 175 836 (26.5) 1295 (34.6) 10 918 (34.2) 91.1 75.0
Sedative/Hypnotic 49 248 (7.4) 369 (9.9) 3172 (9.9) 92.8 78.6
Mood stabilizer 48 743 (7.3) 453 (12.1) 3808 (11.9) 115.4 96.2
Psychotropic dose increase in prior month
Antipsychotic 19 709 (3.0) 178 (4.8) 1430 (4.5) 112.4 92.6
Antidepressant 51 758 (7.8) 411 (11.0) 3439 (10.8) 98.4 80.7
Sedative/Hypnotic 13 970 (2.1) 121 (3.2) 952 (3.0) 107.4 83.6
Mood stabilizer 13 526 (2.0) 137 (3.7) 1108 (3.5) 125.8 101.6
Abbreviation: PPH, potentially preventable hospitalization.
aFor the complete list of characteristics included in the predictive model and model coefficients, see Table S2 and Table S3, respectively.
bCalculated as number of patients with PPH divided by the at-risk days where person-days are counted until the earliest date of PPH, non-PPH admission,
death, or end of follow-up period (30 d for 30-d rate and 12 mo for 12-mo rate) and expressed as per 1000 person-years. Participants who were at risk in
multiple intervals are counted multiple times. In the development cohort, 16 396 (13%) patients were included only once, 15 042 (12%) patients twice,14
049 (11.2%) patients 3 times, 12 868 (10.2%) patients 4 times, 11 567 (9.2%) patients 5 times, 10 921 (8.7%) patients 6 times, 10 714 (8,5%) 7 times, 10
066 (8%) 8 times, 8921 (7.1%) patients 9 times, 6693 (5.3%) 10 times, 4434 (3.5%) 11 times, 2386 (1.9%) patients 12 times, 1092 (.8%) patients 13
times, 358 (.3%) patients 14 times, 84 (.07%) patients 15 times, 14 (.01%) patients 16 times, 2 patients 17 times, and 1 patient 18 times.
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The 12-month PPH admission rate among our population—
57.6 admissions per 1000 person-years in the development
sample—is, as expected for patients with dementia, higher
than for adults overall in the VHA43 and older adults in the
general population.44 However, the rate is lower than in an
analysis of Medicare beneficiaries with dementia.20 This dis-
crepancy between VHA and Medicare PPH rates is partially
because most older VHA patients have Medicare, so some
PPH admissions occur at community facilities. Although this
analysis was not designed to identify particular characteristics
associated with PPH, it is notable that black patients experi-
enced much higher PPH rates than other patients, in a system
designed for equal access to care regardless of socioeconomic
or insurance status.
A limitation of our analysis is that it only includes data
from the VHA. Although this limits generalizability, it sug-
gests feasibility for other healthcare systems to develop and
implement their own internal risk prediction models. The
model only captures PPH risk among patients identified
with a dementia diagnosis that likely represents the subset
Table 2. The 30-day PPH Risk Concentration and Admission Rate by Cut Point of Predicted 30-day PPH Probability
across the Three Cohorts

























Top .1 2.4 24.3 1956.9 2.0 20.4 1635.2 1.9 18.8 1389.0
Top .5 8.4 16.9 1317.0 7.7 15.4 1207.8 7.7 15.4 1113.3
Top 1.0 13.6 13.6 1034.5 14.1 14.1 1092.7 13.4 13.4 953.2
Top 5.0 38.4 7.7 564.6 38.5 7.7 571.8 37.4 7.5 512.0
Top 10.0 53.9 5.4 389.6 53.8 5.4 393.1 52.9 5.3 357.0
Top 20.0 70.3 3.5 250.6 69.5 3.5 250.3 69.3 3.5 230.5
Top 50.0 91.0 1.8 127.8 90.1 1.8 127.8 90.3 1.8 118.4
100.0 100.0 1.0 69.7 100.0 1.0 70.4 100.0 1.0 65.1
Abbreviation: PPH, potentially preventable hospitalization.
aC statistic = .83; 95%CI = .82-.84.
bC statistic = .83; 95%CI = .82-.83.
cC statistic = .82; 95%CI = .82-.83.
dThe percentage of overall cohort PPH admissions accounted for by the patients within a given risk tier.
eRisk concentration = (observed no. of PPHs in risk tier)/(expected no. of PPHs based on rate among older adults with dementia overall).
fCalculated as the number of patients with PPH for each cut point divided by the at-risk days where person-days are counted until the earliest date of PPH,
non-PPH admission, death, or end of follow-up period (30 d) and expressed as per 1000 person-years.
Table 3. Performance Characteristics by Cut Point of
Predicted 30-day PPH Risk in the Prediction Cohort
Predicted probability
cut pointa, % Sensitivity, % Specificity, % PPV, % NPV, %
Top .1 1.9 99.9 9.9 99.5
Top .5 7.7 99.5 8.1 99.5
Top 1.0 13.4 99.1 7.1 99.5
Top 5.0 37.4 95.2 3.9 99.7
Top 10.0 52.9 90.2 2.8 99.7
Top 20.0 69.3 80.3 1.8 99.8
Top 50.0 90.3 50.2 1.0 99.9
100.0 100.0 .0 .5 NA
Abbreviations: NA, due to 0 denominator; NPV, negative predictive value;
PPH, potentially preventable hospitalization; PPV, positive predictive value.
aPerformance characteristics are calculated when those patients whose
predicted 30-day PPH risk probability is at or exceeds the row cut point
are considered positive for PPH and the remaining patients are considered
negative for PPH.
Figure 1. Calibration curve for the predicted 30-day potentially
preventable hospitalization (PPH) risk model applied to the val-
idation cohort. The figure compares observed and expected
(predicted) PPH admissions across deciles of risk among older
adults with dementia in the Veterans Health Administration.
Expected events closely follow observed events, although given
the large sample size, prediction does vary across deciles,
slightly overpredicting risk in the bottom deciles and slightly
underpredicting risk in the top deciles (Hosmer-Lemeshow sta-
tistic: χ2 = 159.8; df = 8; P < .001).
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of patients with more advanced illness. In addition, the pre-
diction data set is drawn from 2012 that is now more than
6 years old. In 2012, the VA introduced the Strategic Ana-
lytics for Improvement and Learning Value Model that
includes PPH as a quality indicator. Heightened attention to
PPH and other systemwide delivery changes mean a model
developed with more recent data may perform differently.
There is controversy over the utility of the PPH construct; a
2016 study found that, of AHRQ-designated preventable
admissions, reviewing clinicians considered less than half pre-
ventable.45 However, Hodgson and colleagues suggest the
PPH construct is still potentially useful, provided it is used to
understand the underlying mechanisms increasing admission
and not just to examine factors associated with admission.46
In this case, although risk prediction may help identify patients
who could benefit from intervention, it cannot suggest the type
of intervention that would be effective.
In conclusion, the acute inpatient hospital is a challeng-
ing environment for older adults with cognitive impairment,
stressful to both patients and their caregivers. It is critical to
address healthcare issues proactively before a crisis occurs
and patients with dementia require hospitalization, particu-
larly as the number of older adults with dementia grows.
This analysis demonstrates that it is possible for healthcare
systems to accurately identify older adults with dementia at
high risk of imminent PPH.
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